Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial
Styrelsen för Internationellt Utvecklingssamarbete
Japan Student Services Organization
National Institutes of Health
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial
Grace Shayo, Furaha Lyamuya, Peter P. Kunambi, Godfrey Barabona et al.
Journal
PLoS ONE
Topics
HIV Research and Treatment
article
Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial
Grace Shayo, Furaha Lyamuya, Peter P. Kunambi, Godfrey Barabona, Philip Sasi, Tosi Mwakyandile, Takamasa Ueno, Ferdinand Mugusi
article en
Abstract
No abstract available for this paper.
Publication Tag
PLoS ONEVol. 20(8)
Institutions
Muhimbili University of Health and Allied Sciences (TZ), Kumamoto University (JP)
Funders
Styrelsen för Internationellt Utvecklingssamarbete, Japan Student Services Organization, National Institutes of Health